Home / Blog
USA Bone Cement Market Size Was Increased To US$ 205.83 Million In 2019
Monday, 22 Jun, 2020
Bone cement, also known as polymethylmethacrylate (PMMA) bone cement, is a self-curing. It provides elasticity by filling the space between prosthesis and the bone. It is a substance used in hip replacement surgery that acts as an adhesive to hold the artificial hip in place. It either comes in a pre-mixed form or as powders and liquids that are mixed in the operating room during surgery. Bone cements are utilized to reinforce stability in bones during an internal fixation surgery. It is also an essential component in many total joint arthroplasty procedures. In a cemented arthroplasty, the main functions of the cement are to immobilize the implant, transfer body weight and service loads from the prosthesis to the bone, and increase the load-carrying capacity of the prosthesis-bone cement-bone system.

The market size of USA bone cement was 205.83 million USD in 2019 and will be 295.8 million USD in 2026 with a CAGR of 5.32%. Besides, the type of High Viscosity Cements has the most obvious growth (CAGR 6.84%), the USA sales of bone cement was reach 4205 K Units in 2019 and it will reach 6213 K Units in 2026 with a CAGR of 5.74%. 

The bone cement can be used in Joint, Vertebral and others. The consumption in joint is still much more than in vertebral, occupying about 72.53% in 2019.

The bone cement can be divided into three types, Low Viscosity Cements, Medium Viscosity Cements and High Viscosity Cements, Low Viscosity Cements occupying about 57.88% in 2019.

We tend to believe this industry will slightly be influenced by the COVID-19 in USA with support by rigid demand in orthopedics, and the consumption increasing degree will show a smooth curve. On product prices, the slow downward trend in recent years will maintain in the future, as competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.

Although sales of bone cement brought a lot of opportunities, for the new entrants with only advantage in capital without sufficient support in technology and downstream channels, the research group did not recommend taking risk the enter this market.